NCT06551311Recruiting
The Effects of Eccentric Cycling Exercise Program in Chronic Kidney Disease Patients
To Explore Efficacy and Load of Eccentric Cycling Training in Older CKD Patients with or Without Sarcopenia
Source: ClinicalTrials.gov · Last updated 24 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Progress in medical technology, enhancements in environmental cleanliness, and elevated living conditions have notably prolonged the mean life expectancy, resulting in a swift increase in the aging population. The prevalence of Chronic Kidney Disease (CKD) is more pronounced among the elderly in contrast to younger demographics. With the aging of the CKD population, the capacity to autonomously handle daily activities becomes a critical concern. This demographic frequently encounters concurrent health conditions, a decrease in self-care capabilities, general health decline, and diminished quality of life. Recent studies suggest that physical activity has the potential to enhance cardiovascular health, cardiopulmonary endurance, muscle strength, quality of life, uremic toxin management, and inflammation levels among individuals with CKD. Given that CKD patients often exhibit sedentary behavior and reduced exercise capacity, eccentric cycling exercises may be particularly well-suited for this demographic. Compared to concentric contractions, eccentric contractions subject the muscles to higher tension. Since muscle growth partially depends on the "stress exerted on muscle fibers"-meaning the greater the stress, the more stimulation the muscles receive-training focused on eccentric contractions could provide more stimulation and promote greater muscle growth. In recent studies, eccentric cycling has emerged as a feasible and promising aerobic exercise intervention. It can provide a safe and appropriate amount of exercise while relatively reducing joint pressure. This novel combined aerobic and anaerobic exercise method is particularly beneficial for individuals with weaker lower limb muscles, lower joint pressure tolerance, poor metabolic and cardiovascular function, and a tendency to fatigue.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- First submitted
- 16 Jul 2024
- Start date
- 1 Jul 2023
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- National Cheng Kung University
- Diseases
- Chronic kidney disease
- NCT number
- NCT06551311
What you commit to
- Study type: Interventional
- Planned participants: 90
- From 1 Jul 2023 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- (1) Clinical diagnosis of acute renal failure
- (2) Hospitalization for acute illness within the past three months
- (3) Clinical diagnosis of severe joint disease and lower extremity surgery
- (4) Clinical diagnosis of severe neurological disease
- (5) Clinical diagnosis of severe cardiovascular disease
Other
- (6) Unconsciousness or lack of ability to cooperate with the assessment
Who the study is looking for
- (1) Clinical diagnosis of CKD
- (2) eGFR \<60 ml/min/1.73m\^2 or undergoing routine dialysis
- (3) Must be able to communicate normally, understand and comply with instructions.
- (4) Must be able to walk independently.
Criteria the registry did not label
- This study will be conducted in collaboration with the Departments of Nephrology and Geriatric Medicine at National Cheng Kung University Hospital, Taiwan. Participants will be recruited as voluntary subjects from outpatient clinics. The attending physician will assess eligible patients. After the study's purpose and methodology are explained by the research staff and patients consent to participate, block randomization will be used to assign participants into one of three groups randomly. The allocation results will be securely stored by the principal investigator.
Age in the registry: 55 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Cheng Kung University Hostipal Coordinator of this site? Confirm its status | Tainan | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.